University Of Valladolid
- Address
- Avenida De Ramon Y Cajal S/n, 47005 Valladolid, Spain
Cardiovascular and Neurological Research
At the University Of Valladolid, clinical trial activity in Cardiovascular Diseases includes research focused on Stroke and related urgent brain-bleeding conditions. The studies are designed to evaluate whether new treatment approaches can improve outcomes and support better clinical decision-making in emergency care.
- Assessing the clinical value of treatments for Intracerebral Haemorrhage
- Studying ways to reduce early death and improve survival after Stroke
- Supporting evidence for faster and more effective acute care
This area of research is centered on testing whether treatment strategies can make a meaningful difference for patients facing time-sensitive neurological emergencies.
Hematology and Cancer Research
The Hematology department at University Of Valladolid is also involved in trials across Neoplasms, with a strong focus on blood cancers such as Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Waldenstrom macroglobulinemia, and Diffuse Large B-Cell Lymphoma. These studies aim to evaluate treatment effectiveness and support ongoing access to therapies that patients are already benefiting from.
- Research in Lymphoma, Leukemia, and Myeloma
- Evaluating long-term benefit from Ibrutinib-based treatment
- Exploring improved care for complex and relapsed Blood Cancers
The trials reflect a broader effort in oncology to maintain effective treatment options and better understand which patients continue to benefit from targeted therapies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1University Of Nottingham1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in University Of Valladolid
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Long-Term Access to Ibrutinib and Drug Combinations for Patients with Lymphomas, Leukemias, Urothelial Carcinoma, Breast Cancer, and Graft vs Host Disease | AbbVie Deutschland GmbH & Co. KG | Phase III | Not Recruiting | Sep 2017 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ibrutinib | 1 | Unknown | 2017-09-28 | 2017-09-28 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.